University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a “two-in-one” molecule that can simultaneously turn off two notoriously difficult-to-target cancer-related genes, KRAS and MYC, as well…
‘Two-in-one’ RNA molecule can simultaneously turn off two difficult-to-target cancer-related genes
